Back to All Decision Makers
Thomas Zipp - Head, Marketing, Halozyme, Inc. | Contact Information, Email Address, Phone Number, Budgets and Responsibilities
|
|
Company
Halozyme, Inc.
2022 Revenue: $660,000,000.00
Halozyme, Inc. is a biotechnology company that discovers, develops, and manufactures enzymes that modulate the extracellular matrix (ECM). The company's lead product is Oncalyst, a recombinant human hyaluronidase, which is used to enhance the delivery of chemotherapy drugs to tumors.
Fiscal Close
December
Founded
1998